First Light Asset Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

First Light Asset Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-19,536	Closed	-$1.27M	–	73
2014 Q1	$1.27M	Buy	19,536 +2,456	+14%	+$166K	0.9%	36
2013 Q4	$962K	Buy	+17,080	New	+$960K	0.82%	37

Other funds holding OREX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Light Asset Management's OREX Position: Q2 2014 in Review

First Light Asset Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2014, closing a stake of 19,536 shares — an estimated $1.27M sold.

First Light Asset Management first reported a position in OREX in Q4 2013 and held it in 2 quarters. The position peaked at $1.27M in Q1 2014. 129 funds tracked by Wall St. Rank hold OREX as of Q2 2014.

First Light Asset Management reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2014 after selling out during the quarter.
First Light Asset Management sold 19,536 Orexigen Therapeutics, Inc. shares in Q2 2014, an estimated $1.27M.
First Light Asset Management first reported a position in Orexigen Therapeutics, Inc. in Q4 2013 and held it in 2 quarters.
First Light Asset Management's Orexigen Therapeutics, Inc. position peaked at $1.27M in Q1 2014.
129 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2014.

Based on First Light Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.